LAM 003 / OrphAI Therap  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LAM 003 / OrphAI Therap
NCT03426605: A Study of LAM-003 in Patients With Acute Myeloid Leukemia

Completed
1
17
US
Open Label LAM-003
OrphAI Therapeutics
Oncology, Acute Myeloid Leukemia
02/20
10/20

Download Options